Das ist Gut! Germany Attracts $6.5 Billion in Pharma-Biotech Capex Investment

Das ist Gut! Germany Attracts $6.5 Billion in Pharma-Biotech Capex Investment

Das ist Gut! Germany Attracts $6.5 Billion in Pharma-Biotech Capex Investment


Attachment: Active Pharma-Bio Projects in Europe

SUGAR LAND--April 14, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)-Germany is an essential part of the Pharmaceutical-Biotech Industry, home to Europe's largest pharmaceutical market, and landing fourth on a global level with its market share of 13.5% in 2016. Its industry prominence is reflected in the $6.5 billion in active reported capital projects, divided among 160 individual projects.

Subscribe Now!(All Fields Required)

Standard Membership - Free